Federal Capture Intelligence

Biological Product (except Diagnostic) Manufacturing contractors at the Department of Health and Human Services

Contract actions: October 1, 2021 – July 27, 2026 Updated July 28, 2026 Department of Health and Human Services agency guide NAICS 325414 · Biological Product (except Diagnostic) Manufacturing
Latest 12 months
$360.3M
Net obligations · Up $81.2M vs. $279.1M preceding
Prime contractors
53
With positive obligations in the latest 12 months

Market snapshot for Biological Product (except Diagnostic) Manufacturing at the Department of Health and Human Services

Federal records show $1.7B in net obligations across 1,917 awards in Biological Product (except Diagnostic) Manufacturing at the Department of Health and Human Services from Oct 1, 2021 through Jul 27, 2026. This market accounts for 1.2% of $140.6B in agency-wide net prime contract obligations over the period shown. Latest 12-month net obligations increased 29.1% from $279.1M to $360.3M. 2 prime contractors accounted for at least 80% of positive obligations in that latest period.

Fiscal-year activity

FY26 is year-to-date through Jul 27, 2026; earlier years show complete fiscal-year totals.

FY26 year-to-date: $302.3M versus −$178.0M through the same date in FY25 (Not comparable).
Net obligations · complete fiscal yearNet obligations · FY26 YTDContract actions
View fiscal-year data table
Fiscal yearNet obligationsContract actionsCoverage
FY2022$386.9M805Complete
FY2023$199.4M622Complete
FY2024$911.6M571Complete
FY2025−$120.0M319Complete
FY2026$302.3M125YTD through Jul 27, 2026

Market at a glance

All reported prime contract awards
All-period net obligations
$1.7B
1,917 awards · 346 prime contractors
Latest 12-month movement
+29.1%
$360.3M vs. $279.1M
Leading eight prime share
98.8%
Share held by the eight leading prime contractors in the latest 12 months
View agency share, denominators, and set-aside reporting
Agency context
1.2% of $140.6B in agency-wide net obligations.
Set-aside share when reported
7.6% of 1,730 awards with reported set-aside status.
Set-aside reporting
132 set aside · 1,598 no set-aside · 187 not reported

What changed in the last 12 months?

Jul 28, 2025–Jul 27, 2026, compared with Jul 28, 2024–Jul 27, 2025.

Competitive shifts

ADVANCED TECHNOLOGY INTERNATIONAL lost the most market share
84.0%→62.0%−22.0 percentage points
The contractor now ranks #1 by positive obligations, based on 17 reported actions.
GLAXOSMITHKLINE, LLC recorded the largest net deobligation
−$13K→−$2.2M−$2.1M
The contractor now is unranked by positive obligations, based on 4 reported actions.

Award activity

Buyer demand

Reported obligations through NATIONAL INSTITUTES OF HEALTH NIAID decreased
$5.7M→$811K−$4.9M
Latest-period activity spans 25 awards across 18 prime contractors.
How these findings are calculated

Findings are selected from matched-period changes in obligations, share, rank, funding offices, concentration, reported set-asides, material award actions, and agency-peer outliers. Related signals are combined, and only material evidence-backed changes are shown. Review the full methodology.

Funding pattern for Biological Product (except Diagnostic) Manufacturing at the Department of Health and Human Services

See how positive obligations were attributed across funding offices in the 12 months ending Jul 27, 2026.

68.4% of positive obligations were attributed to OFC ASST SEC FOR PREPARENESS RES. That represents $251.6M, up $332.4M from the preceding 12 months.

Latest 12-month share of positive obligations; the gray segment represents all other reported offices.

  1. OFC ASST SEC FOR PREPARENESS RES68.4% · $251.6M · up $332.4M
  2. ASPR/ORM-SNS29.6% · $108.8M · up $109.0M
  3. NATIONAL INSTITUTES OF HEALTH OLAO0.57% · $2.1M · up $2.0M
  4. NATIONAL INSTITUTES OF HEALTH NHLBI0.29% · $1.1M · down $13K
  5. NATIONAL INSTITUTES OF HEALTH NIAID0.22% · $811K · down $4.9M
  6. All other reported offices0.92% of positive obligations
View reported office rankings, comparisons, and evidence

USAspending assigns each award to a funding office. That office may differ from the requiring activity, program office, contracting office, individual buyer, or actual customer.

  1. Reported funding office

    OFC ASST SEC FOR PREPARENESS RES

    #1New to the positive-obligation ranking

    Latest 12 months

    $251.6M

    68.4% of positive obligations

    Versus preceding 12 months

    +$332.4M

    2 active prime contractors · 5 awards

    View office comparison and evidence

    Reported obligations moved from $80.8M in net deobligations to $251.6M in net obligations. The office’s share of positive obligations moved from 0% to 68.4%, a change of +68.4 percentage points.

    The latest period contains 9 actions across 5 awards and 1 newly active prime contractor. The preceding period contained 4 active prime contractors and 5 awards.

    Leading award-level changes

  2. Reported funding office

    ASPR/ORM-SNS

    #2New to the positive-obligation ranking

    Latest 12 months

    $108.8M

    29.6% of positive obligations

    Versus preceding 12 months

    +$109.0M

    1 active prime contractor · 1 award

    View office comparison and evidence

    Reported obligations moved from $255K in net deobligations to $108.8M in net obligations. The office’s share of positive obligations moved from 0% to 29.6%, a change of +29.6 percentage points.

    The latest period contains 2 actions across 1 award. The preceding period contained 1 active prime contractor and 1 award.

  3. Reported funding office

    NATIONAL INSTITUTES OF HEALTH OLAO

    #3Up 16 from #19

    Latest 12 months

    $2.1M

    0.57% of positive obligations

    Versus preceding 12 months

    +$2.0M

    9 active prime contractors · 9 awards

    View office comparison and evidence

    Reported obligations increased 4015.2% from $51K to $2.1M. The office’s share of positive obligations moved from 0.010% to 0.57%, a change of +0.6 percentage points.

    The latest period contains 10 actions across 9 awards and 8 newly active prime contractors. The preceding period contained 5 active prime contractors and 9 awards.

  4. Reported funding office

    NATIONAL INSTITUTES OF HEALTH NHLBI

    #4Up 4 from #8

    Latest 12 months

    $1.1M

    0.29% of positive obligations

    Versus preceding 12 months

    −$13K

    16 active prime contractors · 29 awards

    View office comparison and evidence

    Reported obligations decreased 1.2% from $1.1M to $1.1M. The office’s share of positive obligations moved from 0.30% to 0.29%, a change of 0.0 percentage points.

    The latest period contains 31 actions across 29 awards and 9 newly active prime contractors. The preceding period contained 16 active prime contractors and 24 awards.

  5. Reported funding office

    NATIONAL INSTITUTES OF HEALTH NIAID

    #5Down 2 from #3

    Latest 12 months

    $811K

    0.22% of positive obligations

    Versus preceding 12 months

    −$4.9M

    18 active prime contractors · 25 awards

    View office comparison and evidence

    Reported obligations decreased 85.7% from $5.7M to $811K. The office’s share of positive obligations moved from 1.6% to 0.22%, a change of −1.4 percentage points.

    The latest period contains 26 actions across 25 awards and 8 newly active prime contractors. The preceding period contained 51 active prime contractors and 104 awards.

  6. Reported funding office

    NATIONAL INSTITUTES OF HEALTH NHGRI

    #6Up 10 from #16

    Latest 12 months

    $746K

    0.20% of positive obligations

    Versus preceding 12 months

    +$646K

    5 active prime contractors · 5 awards

    View office comparison and evidence

    Reported obligations increased 641.7% from $101K to $746K. The office’s share of positive obligations moved from 0.030% to 0.20%, a change of +0.2 percentage points.

    The latest period contains 5 actions across 5 awards and 4 newly active prime contractors. The preceding period contained 3 active prime contractors and 8 awards.

  7. Reported funding office

    NATIONAL INSTITUTES OF HEALTH - CC

    #7Up 2 from #9

    Latest 12 months

    $686K

    0.19% of positive obligations

    Versus preceding 12 months

    −$254K

    21 active prime contractors · 23 awards

    View office comparison and evidence

    Reported obligations decreased 27.1% from $940K to $686K. The office’s share of positive obligations moved from 0.26% to 0.19%, a change of −0.1 percentage points.

    The latest period contains 24 actions across 23 awards and 12 newly active prime contractors. The preceding period contained 27 active prime contractors and 59 awards.

  8. Reported funding office

    FDA OFFICE OF ACQ GRANT SVCS

    #8Up 4 from #12

    Latest 12 months

    $464K

    0.13% of positive obligations

    Versus preceding 12 months

    +$251K

    8 active prime contractors · 10 awards

    View office comparison and evidence

    Reported obligations increased 117.4% from $214K to $464K. The office’s share of positive obligations moved from 0.060% to 0.13%, a change of +0.1 percentage points.

    The latest period contains 10 actions across 10 awards and 4 newly active prime contractors. The preceding period contained 5 active prime contractors and 7 awards.

  9. Reported funding office

    NATIONAL INSTITUTES OF HEALTH NIA

    #9Down 2 from #7

    Latest 12 months

    $387K

    0.11% of positive obligations

    Versus preceding 12 months

    −$1.3M

    9 active prime contractors · 10 awards

    View office comparison and evidence

    Reported obligations decreased 76.7% from $1.7M to $387K. The office’s share of positive obligations moved from 0.46% to 0.11%, a change of −0.3 percentage points.

    The latest period contains 10 actions across 10 awards and 7 newly active prime contractors. The preceding period contained 7 active prime contractors and 7 awards.

  10. Reported funding office

    NATIONAL INSTITUTES OF HEALTH NINDS

    #10Up 10 from #20

    Latest 12 months

    $299K

    0.080% of positive obligations

    Versus preceding 12 months

    +$249K

    2 active prime contractors · 2 awards

    View office comparison and evidence

    Reported obligations increased 496.3% from $50K to $299K. The office’s share of positive obligations moved from 0.010% to 0.080%, a change of +0.1 percentage points.

    The latest period contains 2 actions across 2 awards and 2 newly active prime contractors. The preceding period contained 2 active prime contractors and 3 awards.

  11. Reported funding office

    CDC OFFICE OF ACQUISITION SERVICES

    #11Down 6 from #5

    Latest 12 months

    $255K

    0.070% of positive obligations

    Versus preceding 12 months

    −$1.8M

    13 active prime contractors · 14 awards

    View office comparison and evidence

    Reported obligations decreased 87.3% from $2.0M to $255K. The office’s share of positive obligations moved from 0.56% to 0.070%, a change of −0.5 percentage points.

    The latest period contains 17 actions across 14 awards and 1 newly active prime contractor. The preceding period contained 29 active prime contractors and 32 awards.

  12. Reported funding office

    INDUSTRIAL BASED MANUFACTURING AND SUPPLY CHAIN (IBMSC)

    No positive-obligation rank

    Latest 12 months

    $0

    0% of positive obligations

    Versus preceding 12 months

    −$309.5M

    0 active prime contractors · 0 awards

    View office comparison and evidence

    Reported obligations decreased 100.0% from $309.5M to $0. The office’s share of positive obligations moved from 85.9% to 0%, a change of −85.9 percentage points.

    The latest period contains 0 actions across 0 awards. The preceding period contained 1 active prime contractor and 4 awards.

    Leading award-level changes

  13. Reported funding office

    ASPR BARDA DIV CONTRACTS MGMT & ACQ

    No positive-obligation rank

    Latest 12 months

    $0

    0% of positive obligations

    Versus preceding 12 months

    −$3.9M

    0 active prime contractors · 0 awards

    View office comparison and evidence

    Reported obligations decreased 100.0% from $3.9M to $0. The office’s share of positive obligations moved from 1.1% to 0%, a change of −1.1 percentage points.

    The latest period contains 0 actions across 0 awards. The preceding period contained 2 active prime contractors and 2 awards.

  14. Reported funding office

    BARDA - ASPR / DAAPPO / BARDA DCMA

    No positive-obligation rank

    Latest 12 months

    −$7.4M

    0% of positive obligations

    Versus preceding 12 months

    −$39.4M

    7 active prime contractors · 18 awards

    View office comparison and evidence

    Reported obligations moved from $32.0M in net obligations to $7.4M in net deobligations. The office’s share of positive obligations moved from 8.9% to 0%, a change of −8.9 percentage points.

    The latest period contains 27 actions across 18 awards and 3 newly active prime contractors. The preceding period contained 9 active prime contractors and 38 awards.

How this work is bought

Reported award structure, competition, pricing, work categories, and contracting channels for Biological Product (except Diagnostic) Manufacturing at the Department of Health and Human Services.

During Jul 28, 2025–Jul 27, 2026, this market recorded $377.9M in positive net award obligations across 94 awards. The leading reported procedure, Negotiated Proposal/Quote, accounted for 90.9% of that positive-obligation base. Awards with a reported parent IDV accounted for 62.8%.

Leading award type
62.7%
Delivery Order
Leading reported procedure
90.9%
Negotiated Proposal/Quote
Reported parent IDV
62.8%
of positive obligations had a reported parent IDV
Median reported offers
1
83 of 94 awards reported offers

Buying method changes

Compared with Jul 28, 2024–Jul 27, 2025. Based on 94 current awards and 267 preceding awards with positive net obligations.

Parent-IDV obligation share
62.8%
Down from 90.7% in the preceding period
How to read these changes

Directional color and the Up or Down labels show historical movement only. Green does not mean favorable and red does not mean unfavorable; neither predicts a future procurement method.

Same-NAICS comparison

Compared with the NAICS 325414 peer median, parent-IDV obligation share is 36.8 percentage points lower, reported full-and-open obligation share is 65.9 percentage points higher, delivery-order obligation share is 36.5 percentage points lower, and median positive award obligations are 73.2% lower.

MeasureThis marketPeer medianDifference
Parent-IDV obligation share62.8%99.5%-36.8 pts
Reported full-and-open obligation share90.9%25.0%+65.9 pts
Delivery-order obligation share62.7%99.2%-36.5 pts
Median positive award obligations$25K$93K-73.2%
Peer cohort and comparison limits

The peer median gives each of the 3 eligible agency markets equal weight. The included agency markets are:

Agency mission, scale, and acquisition context can differ. Peer position does not establish market attractiveness or predict a future procurement method.

View buying-method details and data coverage

Award types

Reported valueAwardsPositive obligationsShare
Delivery Order(C)11$237.1M62.7%
Definitive Contract(D)4$135.6M35.9%
Purchase Order(B)70$5.0M1.3%
BPA Call(A)9$165K0.040%

Reported parent-award types

Reported valueAwardsPositive obligationsShare
IDC(B)11$237.1M62.7%
BPA(E)9$165K0.040%
Not reported74$140.7M37.2%

Single- or multiple-award parent structure

Reported valueAwardsPositive obligationsShare
Single Award(S)20$237.3M62.8%
Not reported74$140.7M37.2%

Solicitation procedures

Reported valueAwardsPositive obligationsShare
Negotiated Proposal/Quote(NP)6$343.4M90.9%
Only One Source(SSS)13$28.1M7.4%
Simplified Acquisition(SP1)75$6.5M1.7%

Extent competed

Reported valueAwardsPositive obligationsShare
Full And Open Competition(A)6$343.4M90.9%
Not Competed(C)13$28.1M7.4%
Not Competed Under SAP(G)31$3.7M0.98%
Competed Under SAP(F)44$2.8M0.73%

Fair-opportunity and limited-source reporting

Reported valueAwardsPositive obligationsShare
Not reported94$377.9M100.0%

Other-than-full-and-open reasons

Reported valueAwardsPositive obligationsShare
Only One Source-Other (FAR 6.302-1 Other)(ONE)13$28.1M7.4%
SAP Non-Competition (FAR 13)(SP2)25$3.6M0.96%
Authorized By Statute (FAR 6.302-5(A)(2)(I))(OTH)5$76K0.020%
Less Than Or Equal To The Micro-Purchase Threshold(MPT)1$7580%
Not reported50$346.1M91.6%

Contract pricing types

Reported valueAwardsPositive obligationsShare
Cost Plus Fixed Fee(U)2$251.6M66.6%
Firm Fixed Price(J)92$126.3M33.4%

Product or Service Codes

Reported valueAwardsPositive obligationsShare
Health R&d Services; Health Care - Other; Applied Research(AN42)1$225.0M59.5%
Medical And Surgical Instruments, Equipment, And Supplies(6515)1$108.8M28.8%
Medical- Other(Q999)1$26.6M7.0%
Drugs And Biologicals(6505)44$12.2M3.2%
In Vitro Diagnostic Substances, Reagents, Test Kits And Sets(6550)28$2.1M0.54%
Laboratory Equipment And Supplies(6640)10$1.6M0.42%
Other reported values9$1.7M0.44%

Awarding subagencies

Reported valueAwardsPositive obligationsShare
Office of Assistant Secretary for Preparedness and Response(7505)7$370.0M97.9%
National Institutes of Health(7529)77$7.0M1.9%
Food and Drug Administration(7524)4$466K0.12%
Centers for Disease Control and Prevention(7523)4$360K0.10%
Departmental Offices(1406)2$87K0.020%

Awarding offices

Reported valueAwardsPositive obligationsShare
Barda - Aspr / Daappo / Barda Dcma(75A501)6$261.2M69.1%
Aspr/Orm-Sns(75A503)1$108.8M28.8%
National Institutes Of Health Olao(75N980)17$2.9M0.78%
National Institutes Of Health Nhlbi(75N920)22$1.5M0.39%
National Institutes Of Health - Cc(75N900)9$1.2M0.32%
National Institutes Of Health Niaid(75N930)6$853K0.23%
Other reported values33$1.5M0.39%

Reported parent IDVs

Reported valueAwardsPositive obligationsShare
75A50123D00003(7505)1$225.0M59.5%
75A50122D00004(7505)4$9.6M2.5%
75N90023D00015(7529)2$1.7M0.45%
75N90023D00008(7529)1$330K0.090%
75F40125D00013(7524)2$262K0.070%
75N90024D00008(7529)1$227K0.060%
75N98025A00002(7529)6$119K0.030%
75N98024A00047(7529)1$23K0.010%
Other reported values2$23K0.0062%
Not reported74$140.7M37.2%

Offers, award size, and timing

Median reported offers
1 median
83 reported · 11 not reported
Positive award obligations
$25K median
$16K–$100K middle 50%
Reported performance period
180 days (~6 months) median
94 reported · 0 not reported

Calculations group latest-period actions by award, retain awards with positive net obligations for share denominators, and use each award's latest reported USAspending procurement fields as of Jul 27, 2026. Blank competition, pricing, PSC, or parent-IDV values remain not reported; they are not inferred. Offer counts must be positive and below the FPDS 999 placeholder. Awarding organizations can differ from the funding agency that defines this page.

Prime contractors for Biological Product (except Diagnostic) Manufacturing at the Department of Health and Human Services

Latest 12-month concentration and complete prime contractor rankings across the period shown.

Prime contractor concentration
2 of 53prime contractors account for at least 80% of positive obligations in the last 12 months
Largest prime contractor
62.0%of positive obligations in the last 12 months
Leading four prime contractors
97.9%of positive obligations in the last 12 months
Leading eight prime contractors
98.8%of positive obligations in the last 12 months

Based on $363.0M in positive obligations during the 12 months ending Jul 27, 2026. Individual shares and movement appear in the searchable rankings below. Movement compares with Jul 28, 2024–Jul 27, 2025.

Last 12mo obligation volume: Highest positive obligations first; net deobligations follow by magnitude; contractors with no activity in the last 12 months follow by all-period obligations. Ranks use the complete contractor list and remain fixed when search narrows the results.

15 leading contractors
  1. #1

    Last 12mo obligations

    $225.0M

    62.0%

    Dollar movement

    −$122.6M

    vs. prior 12 months

    Last 12mo awards

    9 awards

    17 actions

    Historical and award details for ADVANCED TECHNOLOGY INTERNATIONAL
    Obligations: prior → latest
    $347.6M → $225.0M
    −35.3%
    Share: prior → latest
    84.0% → 62.0%
    −22.0 percentage points
    All-period obligations
    $911.5M
    50.0% of all-period positive obligations · 9 awards
    Recorded activity
    Since Dec 12, 2023
    through May 7, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside00
    Not reported99
    Reported small business00
    All-period set-aside types

    None reported.

  2. #2

    Last 12mo obligations

    $108.8M

    30.0%

    Dollar movement

    +$109.0M

    vs. prior 12 months

    Last 12mo awards

    1 award

    2 actions

    Historical and award details for EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.
    Obligations: prior → latest
    −$255K → $108.8M
    Not comparable
    Share: prior → latest
    0% → 30.0%
    +30.0 percentage points
    All-period obligations
    $328.4M
    18.0% of all-period positive obligations · 1 award
    Recorded activity
    Since Oct 25, 2021
    through Jun 26, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside11
    Not reported00
    Reported small business00
    All-period set-aside types

    None reported.

  3. #3

    Last 12mo obligations

    $12.0M

    3.3%

    Dollar movement

    −$13.8M

    vs. prior 12 months

    Last 12mo awards

    2 awards

    3 actions

    Historical and award details for SANOFI VACCINES US INC.
    Obligations: prior → latest
    $25.9M → $12.0M
    −53.5%
    Share: prior → latest
    6.3% → 3.3%
    −2.9 percentage points
    All-period obligations
    $39.6M
    2.2% of all-period positive obligations · 46 awards
    Recorded activity
    Since Oct 27, 2021
    through Apr 8, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside23
    Not reported05
    Reported small business00
    All-period set-aside types

    None reported.

  4. #4

    Last 12mo obligations

    $9.6M

    2.6%

    Dollar movement

    −$15.4M

    vs. prior 12 months

    Last 12mo awards

    5 awards

    9 actions

    Historical and award details for SEQIRUS INC
    Obligations: prior → latest
    $25.0M → $9.6M
    −61.7%
    Share: prior → latest
    6.0% → 2.6%
    −3.4 percentage points
    All-period obligations
    $89.3M
    4.9% of all-period positive obligations · 27 awards
    Recorded activity
    Since Feb 22, 2022
    through May 8, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside00
    Not reported510
    Reported small business00
    All-period set-aside types

    None reported.

  5. #5

    Last 12mo obligations

    $1.5M

    0.40%

    Dollar movement

    +$1.4M

    vs. prior 12 months

    Last 12mo awards

    3 awards

    4 actions

    Historical and award details for MILTENYI BIOTEC, INC.
    Obligations: prior → latest
    $21K → $1.5M
    +6868.5%
    Share: prior → latest
    0.010% → 0.40%
    +0.4 percentage points
    All-period obligations
    $2.2M
    0.12% of all-period positive obligations · 5 awards
    Recorded activity
    Since Jun 29, 2022
    through Jun 25, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside01
    Not reported30
    Reported small business00
    All-period set-aside types

    None reported.

  6. #6

    Last 12mo obligations

    $655K

    0.18%

    Dollar movement

    −$378K

    vs. prior 12 months

    Last 12mo awards

    8 awards

    8 actions

    Historical and award details for 10X GENOMICS, INC.
    Obligations: prior → latest
    $1.0M → $655K
    −36.6%
    Share: prior → latest
    0.25% → 0.18%
    −0.1 percentage points
    All-period obligations
    $6.1M
    0.34% of all-period positive obligations · 151 awards
    Recorded activity
    Since Nov 22, 2021
    through Mar 6, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside313
    Reported no set-aside59
    Not reported00
    Reported small business315
    All-period set-aside types
    • 88 · Total small business
  7. #7

    Last 12mo obligations

    $653K

    0.18%

    Dollar movement

    −$762K

    vs. prior 12 months

    Last 12mo awards

    2 awards

    2 actions

    Historical and award details for VECTOR BIOMED INC.
    Obligations: prior → latest
    $1.4M → $653K
    −53.9%
    Share: prior → latest
    0.34% → 0.18%
    −0.2 percentage points
    All-period obligations
    $2.1M
    0.11% of all-period positive obligations · 3 awards
    Recorded activity
    Since Aug 29, 2024
    through Jun 23, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside22
    Not reported00
    Reported small business22
    All-period set-aside types

    None reported.

  8. #8

    Last 12mo obligations

    $538K

    0.15%

    Dollar movement

    −$1.8M

    vs. prior 12 months

    Last 12mo awards

    2 awards

    2 actions

    Historical and award details for SOMALOGIC OPERATING CO., INC
    Obligations: prior → latest
    $2.3M → $538K
    −76.6%
    Share: prior → latest
    0.56% → 0.15%
    −0.4 percentage points
    All-period obligations
    $4.1M
    0.22% of all-period positive obligations · 13 awards
    Recorded activity
    Since Jan 28, 2022
    through May 18, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside23
    Not reported00
    Reported small business13
    All-period set-aside types

    None reported.

  9. #9

    Last 12mo obligations

    $376K

    0.10%

    Dollar movement

    +$301K

    vs. prior 12 months

    Last 12mo awards

    1 award

    1 action

    Historical and award details for OXFORD NANOPORE TECHNOLOGIES INC
    Obligations: prior → latest
    $75K → $376K
    +400.5%
    Share: prior → latest
    0.020% → 0.10%
    +0.1 percentage points
    All-period obligations
    $494K
    0.030% of all-period positive obligations · 4 awards
    Recorded activity
    Since Jun 27, 2023
    through Sep 12, 2025

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside11
    Not reported00
    Reported small business01
    All-period set-aside types

    None reported.

  10. #10

    Last 12mo obligations

    $347K

    0.10%

    Dollar movement

    +$348K

    vs. prior 12 months

    Last 12mo awards

    2 awards

    2 actions

    Historical and award details for PACIFIC BIOSCIENCES OF CALIFORNIA, INC
    Obligations: prior → latest
    −$1K → $347K
    Not comparable
    Share: prior → latest
    0% → 0.10%
    +0.1 percentage points
    All-period obligations
    $656K
    0.040% of all-period positive obligations · 18 awards
    Recorded activity
    Since Nov 5, 2021
    through Jul 7, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside24
    Not reported00
    Reported small business22
    All-period set-aside types
    • 2 · Total small business
  11. #11

    Last 12mo obligations

    $330K

    0.090%

    Dollar movement

    +$330K

    vs. prior 12 months

    Last 12mo awards

    1 award

    2 actions

    Historical and award details for HOLOGIC SALES AND SERVICE, LLC
    Obligations: prior → latest
    $0 → $330K
    Not comparable
    Share: prior → latest
    0% → 0.090%
    +0.1 percentage points
    All-period obligations
    $566K
    0.030% of all-period positive obligations · 2 awards
    Recorded activity
    Since Dec 7, 2022
    through Mar 2, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside00
    Not reported10
    Reported small business00
    All-period set-aside types

    None reported.

  12. #12

    Last 12mo obligations

    $262K

    0.070%

    Dollar movement

    +$172K

    vs. prior 12 months

    Last 12mo awards

    2 awards

    2 actions

    Historical and award details for FUJIFILM BIOSCIENCES INC.
    Obligations: prior → latest
    $90K → $262K
    +192.4%
    Share: prior → latest
    0.020% → 0.070%
    +0.1 percentage points
    All-period obligations
    $416K
    0.020% of all-period positive obligations · 5 awards
    Recorded activity
    Since Aug 17, 2022
    through Jul 8, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside01
    Not reported20
    Reported small business20
    All-period set-aside types

    None reported.

  13. #13

    Last 12mo obligations

    $261K

    0.070%

    Dollar movement

    +$160K

    vs. prior 12 months

    Last 12mo awards

    2 awards

    2 actions

    Historical and award details for AGILENT TECHNOLOGIES INC
    Obligations: prior → latest
    $101K → $261K
    +159.4%
    Share: prior → latest
    0.020% → 0.070%
    +0.1 percentage points
    All-period obligations
    $918K
    0.050% of all-period positive obligations · 33 awards
    Recorded activity
    Since Dec 8, 2021
    through Sep 23, 2025

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside25
    Not reported00
    Reported small business00
    All-period set-aside types

    None reported.

  14. #14

    Last 12mo obligations

    $250K

    0.070%

    Dollar movement

    $0

    no change vs. prior 12 months

    Last 12mo awards

    1 award

    1 action

    Historical and award details for UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.
    Obligations: prior → latest
    $250K → $250K
    +0.0%
    Share: prior → latest
    0.060% → 0.070%
    0.0 percentage points
    All-period obligations
    $1.2M
    0.070% of all-period positive obligations · 1 award
    Recorded activity
    Since Jun 28, 2022
    through Jul 8, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside11
    Not reported00
    Reported small business00
    All-period set-aside types

    None reported.

  15. #15

    Last 12mo obligations

    $249K

    0.070%

    Dollar movement

    −$1.3M

    vs. prior 12 months

    Last 12mo awards

    1 award

    1 action

    Historical and award details for JACKSON LABORATORY
    Obligations: prior → latest
    $1.5M → $249K
    −83.7%
    Share: prior → latest
    0.37% → 0.070%
    −0.3 percentage points
    All-period obligations
    $3.2M
    0.17% of all-period positive obligations · 5 awards
    Recorded activity
    Since Aug 31, 2022
    through Jul 1, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside11
    Not reported00
    Reported small business00
    All-period set-aside types

    None reported.

Recompete watch for Biological Product (except Diagnostic) Manufacturing at the Department of Health and Human Services

Investigate potential recompetes surfaced by near-term end dates, award value, and recent contract changes.

ADVANCED TECHNOLOGY INTERNATIONAL

OT: THE PURPOSE OF THIS MODIFICATION IS TO ADMINISTRATIVELY UPDATE ATTACHMENT 1, SECTION 7. TASK ORDER POINTS OF CONTACT

$248.5M is obligated on an award with a reported potential end date of September 29, 2027.

Performance period

60.9%

As of Jul 27, 2026Potential end Sep 29, 2027

Current award value as a share of potential value

100.0%

$248.5M current$248.5M potential
Supporting data

Reported performance starts Sep 27, 2024.

No later potential end date is reported; current and potential end dates are both Sep 29, 2027.

$248.5M is obligated against $248.5M in current reported award value (100.0%).

Obligations are compared with current reported award value, not treated as a contract ceiling.

PIID 75A50424F64001

CANGENE CORPORATION

ADD FUNDING.

$510.9M is obligated on an award with a reported potential end date of December 31, 2027.

Performance period

93.4%

As of Jul 27, 2026Potential end Dec 31, 2027

Current award value as a share of potential value

86.0%

$510.9M current$594.2M potential
Supporting data

Reported performance starts May 30, 2006.

No later potential end date is reported; current and potential end dates are both Dec 31, 2027.

$510.9M is obligated against $510.9M in current reported award value (100.0%).

Obligations are compared with current reported award value, not treated as a contract ceiling.

PIID HHSO100200600017C

These are research leads, not confirmed recompetes. USAspending records through Jul 27, 2026; reported dates and values can change through later modifications.

Award activity for Biological Product (except Diagnostic) Manufacturing at the Department of Health and Human Services

Recent contract actions with unusually large obligation changes or meaningful shifts in contractor and funding-office activity.

Modification

This action

+$56.0M

EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.

ASPR/ORM-SNS

ACAM2000, SMALLPOX (VACCINIA) VACCINE, LIVE (ACAM)

Why it stands out

The award grew alongside stronger contractor activity.

The modification added $56.0M while contractor obligations rose $109.0M overall.

Award net obligations
$857.6M
Share of 12-month positive obligations
15.4%
Supporting data
Prime contractor
#2 · 30.0% share
+30.0 percentage points · $109.0M net increase; action accounted for 51.4%
Funding office
#2 · 29.6% attributed share
+29.6 percentage points · $109.0M net increase; action accounted for 51.4%
PIID 75A50119C00071 · Mod P00014
Modification

This action

+$210.0M

ADVANCED TECHNOLOGY INTERNATIONAL

OFC ASST SEC FOR PREPARENESS RES

OTA: THE PURPOSE OF THIS MODIFICATION IS TO INCREASE THE TOTAL ESTIMATED COST AND ADD FUNDING.

Why it stands out

One action equaled at least half of the market’s latest 12-month positive obligations.

The $210.0M action represented 57.9% of the market’s positive obligations over the latest 12 months.

Award net obligations
$304.0M
Share of 12-month positive obligations
57.9%
Supporting data
Prime contractor
#1 · 62.0% share
$122.6M net decline despite this positive action
Funding office
#1 · 68.4% attributed share
+68.4 percentage points · $332.4M net increase; action accounted for 63.2%
Related:Unusually large action
PIID 75A50124F61002 · Mod P00009
Deobligation

This action

−$14.6M

SANOFI VACCINES US INC.

BARDA - ASPR / DAAPPO / BARDA DCMA

NO-COST SUPPLEMENTAL AGREEMENT TO INCORPORATE BY EXECUTIVE ORDER 14042 - FAR DEVIATION CLAUSE 52.223-99, ENSURING ADEQUATE COVID SAFETY PROTOCOLS FOR FEDERAL CONTRACTORS. NO OTHER CHANGES APPLY.

Why it stands out

This award recorded a material contraction.

The action removed $14.6M. A deobligation does not by itself show lower requirement demand.

Award net obligations
$18.8M
Share of 12-month positive obligations
4.0%
Supporting data
Prime contractor
#3 · 3.3% share
down 1 rank · −2.9 percentage points · $13.8M net decline; action exceeded it by $753K
Funding office
0% attributed share
−8.9 percentage points · $39.4M net decline; action accounted for 37.0%
PIID HHSO100201600039C · Mod P00008
Modification

This action

+$8.4M

SEQIRUS INC

BARDA - ASPR / DAAPPO / BARDA DCMA

THE PURPOSE OF THIS TASK ORDER IS TO PROCURE SERVICES FOR STORAGE AND STABILITY VACCINE BULK LOTS FROM PRIOR CONTRACTS FOR DEPARTMENT OF HEALTH AND HUMAN SERVICES UNDER IDIQ CONTRACT #75A50122D00004.

Why it stands out

This award grew while spending attributed to its office declined.

The modification added $8.4M while office-attributed obligations fell $39.4M overall.

Award net obligations
$23.3M
Share of 12-month positive obligations
2.3%
Supporting data
Prime contractor
#4 · 2.6% share
$15.4M net decline despite this positive action
Funding office
0% attributed share
$39.4M net decline despite this positive action
PIID 75A50124F61008 · Mod P00008
Deobligation

This action

−$1.5M

GLAXOSMITHKLINE, LLC

BARDA - ASPR / DAAPPO / BARDA DCMA

THE PURPOSE OF THIS MODIFICATION IS TO: 1. EXERCISE FAR 52.217-8, OPTION TO EXTEND SERVICES FOR SIX (6) MONTHS. 2. AS RESULT OF THIS MODIFICATION, THE PERIOD OF PERFORMANCE FOR THE OPTION PERIOD 2 IS HEREBY CHANGED FROM 08/22/2020 - 08/21/2021 TO

Why it stands out

This award recorded a material contraction.

The action removed $1.5M. A deobligation does not by itself show lower requirement demand.

Award net obligations
$4.9M
Share of 12-month positive obligations
0.42%
PIID 75A50119F33008 · Mod P00011
Base award

This action

+$1.0M

MILTENYI BIOTEC, INC.

NATIONAL INSTITUTES OF HEALTH OLAO

ADDING LINE ITEM 9: OPTION YEAR THREE (3) POP 03/13/2026-09/30/2026

Why it stands out

The contractor climbed 70 positions in this market.

It now ranks #5 by positive obligations over the latest 12 months.

Award net obligations
$1.2M
Share of 12-month positive obligations
0.28%
Supporting data
Prime contractor
#5 · 0.40% share
up 70 ranks · +0.4 percentage points · $1.4M net increase; action accounted for 69.6%
Funding office
#3 · 0.57% attributed share
up 16 ranks · +0.6 percentage points · $2.0M net increase; action accounted for 49.1%
PIID 75N98026F00003
View recent award activity by date (10)
  1. ACROBIOSYSTEMS INCBase award · PIID 75N98026P01080
    Action+$22K
    Award net obligations$22K
  2. HEYLTEX CORPORATIONDeobligation · PIID HHSO100201100008C
    Action−$234K
    Award net obligations$17.2M
  3. DNA TWOPOINTO INC.Modification · PIID 75N93023P00594
    Action+$75K
    Award net obligations$300K
  4. TAKARA BIO USA, INC.Deobligation · PIID 75N92B21P00064
    Action−$100
    Award net obligations$11K
  5. ALDEVRON, L.L.CDeobligation · PIID 75N91021P00243
    Action−$1
    Award net obligations$15K
  6. MOLECULAR INSTRUMENTS, INCDeobligation · PIID 75N92C21P00048
    Action−$5
    Award net obligations$10K
  7. UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.Modification · PIID 75D30122C14299
    Action+$250K
    Award net obligations$1.2M
  8. EMD MILLIPORE CORPBase award · PIID 75N98026P00978
    Action+$27K
    Award net obligations$27K
  9. FUJIFILM BIOSCIENCES INC.Base award · PIID 75F40126F19002
    Action+$15K
    Award net obligations$15K
  10. PACIFIC BIOSCIENCES OF CALIFORNIA, INCBase award · PIID 75N98026P00928
    Action+$347K
    Award net obligations$347K

Apply this research to a live pursuit

Sweetspot connects opportunity qualification, competitive research, capture, and proposal work in one workspace.

See Sweetspot in action

Related market research

Complete market indexes:

Same NAICS at other agencies:

Nearby NAICS at this agency:

Markets sharing leading prime records:

Leading-prime vehicle memberships:

Company memberships do not establish award-channel use.

Reported obligations include contract actions from October 1, 2021 through July 27, 2026. Set-aside and business-size fields reflect award records, not a contractor's current eligibility.

Review data methodology